Skip to main content

Pharmapedia

 

Clinical courses

 

Clinical courses

  • ADVANCES IN HOSPITAL PHARMACY SERVICES: AN OVERVIEW

    ABOUT AUTHOR
    Dr. R. S. Thakur
    Email: drramsthakur@gmail.com
    Phone: +91-9740802164

    Preamble
    Health has direct impact on socio-economic growth of the country and welfare of its people. Hospital Pharmacy of a Hospital or other Health Care Facilities makes available drugs, devices, and other materials used in the diagnosis, mitigation, prevention and treatment of injury, illness, and disease. Hospital Pharmacy procures, stores and supplies medicines for dispensing, compounding, distribution and provides Pharmaceutical Care. Talking from a patient’s perspective, hospital pharmacy services provide medicines, information and advice to inpatients and outpatients as well as to the health professionals and others giving health care to the patients. 

  • What are the skills required to be a Pharmacist?

  • How do I get a job in pharmaceutical industry?

  • COVID-19: Myths Vs Facts

    Here, we have presented with Facts of corona virus (COVID-19) as per World Health Organization (WHO). Do not be panic and follow the instructions by government and other health authorities

  • Foreign direct investment (FDI) is continuously declining in India. It is second time since 2014, there is a steady decline reported in 2019-20. It was Rs. 9994 crores in 2014-15 and declined to Rs. 2496 crore in 2019-2020 as reported by department of pharmaceuticals.

  • List of Top Pharmaceutical companies in India 2020

    List of Top Pharmaceutical companies in India 2020

  • Highest Pharmaceutical mergers and acquisitions of 2019

    Mergers and acquisitions (M&As) are perpetual part of big pharmaceutical industries and we have witnessed many such mergers and acquisitions. The financial crisis and resulting uncertainty in the global economies has made it difficult for companies to predict future performance of their own or their targets or to forecast synergies and other transaction benefits with the same level of confidence seen in the past. As a result, acquirors and targets have developed transaction structures that are aimed at bridging gaps in their respective assessments of valuation and risk.

    This article is focusing on top Pharmaceutical M&As of the year 2019.

  • Antibiotic resistance (AMR) is rising to dangerously high levels in all parts of the world. New resistance mechanisms are emerging and spreading globally, threatening our ability to treat common infectious diseases. Antimicrobial Resistance is an increasingly serious threat to public health. The spread of multi-drug resistant bacteria and the lack of new antibiotics to treat infections caused by these organisms pose a rapidly increasing threat to human health which urgently needs to be tackled.

  • Decreasing Therapy Cost, For people by People: Collobrative approach

    Development of new biopharmaceutical for different patient's need is now in some limited hand due to high R&D (Research and Development) cost and making therapy are not affordable for large segment of people in developing country.

Subscribe to Pharmapedia